 | • レポートコード：MRC2Q12-18264 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、敗血症診断のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 敗血症診断のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 敗血症診断の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 敗血症診断のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの敗血症診断の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の敗血症診断の売上および2028年までの予測に焦点を当てています。 敗血症診断のグローバル主要企業には、Diasorin、Abbott、Roche Holding AG、BioMérieux、Becton Dickinson、Bruker、Beckman Coulter、Luminex Corporation、McKesson Corporationなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 敗血症診断市場は、タイプとアプリケーションによって区分されます。世界の敗血症診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 実験室試験、PoC試験、その他 【アプリケーション別セグメント】 クリニック、診断センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 敗血症診断製品概要 - タイプ別市場（実験室試験、PoC試験、その他） - アプリケーション別市場（クリニック、診断センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の敗血症診断販売量予測2017-2028 - 世界の敗血症診断売上予測2017-2028 - 敗血症診断の地域別販売量 - 敗血症診断の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別敗血症診断販売量 - 主要メーカー別敗血症診断売上 - 主要メーカー別敗血症診断価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（実験室試験、PoC試験、その他） - 敗血症診断のタイプ別販売量 - 敗血症診断のタイプ別売上 - 敗血症診断のタイプ別価格 ・アプリケーション別市場規模（クリニック、診断センター、その他） - 敗血症診断のアプリケーション別販売量 - 敗血症診断のアプリケーション別売上 - 敗血症診断のアプリケーション別価格 ・北米市場 - 北米の敗血症診断市場規模（タイプ別、アプリケーション別） - 主要国別の敗血症診断市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの敗血症診断市場規模（タイプ別、アプリケーション別） - 主要国別の敗血症診断市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の敗血症診断市場規模（タイプ別、アプリケーション別） - 主要国別の敗血症診断市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の敗血症診断市場規模（タイプ別、アプリケーション別） - 主要国別の敗血症診断市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの敗血症診断市場規模（タイプ別、アプリケーション別） - 主要国別の敗血症診断市場規模（トルコ、サウジアラビア） ・企業情報 Diasorin、Abbott、Roche Holding AG、BioMérieux、Becton Dickinson、Bruker、Beckman Coulter、Luminex Corporation、McKesson Corporation ・産業チェーン及び販売チャネル分析 - 敗血症診断の産業チェーン分析 - 敗血症診断の原材料 - 敗血症診断の生産プロセス - 敗血症診断の販売及びマーケティング - 敗血症診断の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 敗血症診断の産業動向 - 敗血症診断のマーケットドライバー - 敗血症診断の課題 - 敗血症診断の阻害要因 ・主な調査結果 |
Sepsis is a life-threatening organ dysfunction when the body’s immune system attacks its organs and tissues in reaction to an infection. Chronic sickness, a weakened immune system, renal or liver disease, cancer, and serious wounds can all cause it. There is no confirmatory diagnostic test, and sepsis diagnosis requires clinical judgment based on infection and organ dysfunction evidence.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Septicemia Diagnostic estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Septicemia Diagnostic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Septicemia Diagnostic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Septicemia Diagnostic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Septicemia Diagnostic include Diasorin, Abbott, Roche Holding AG, BioMérieux, Becton Dickinson, Bruker, Beckman Coulter, Luminex Corporation and McKesson Corporation, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Septicemia Diagnostic companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Septicemia Diagnostic market. Further, it explains the major drivers and regional dynamics of the global Septicemia Diagnostic market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Diasorin
Abbott
Roche Holding AG
BioMérieux
Becton Dickinson
Bruker
Beckman Coulter
Luminex Corporation
McKesson Corporation
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Septicemia Diagnostic Segment by Type
Laboratory Testing
PoC Testing
Others
Septicemia Diagnostic Segment by Application
Clinics
Diagnostic Centers
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Septicemia Diagnostic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Septicemia Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Septicemia Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Septicemia Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Septicemia Diagnostic revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Septicemia Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Septicemia Diagnostic revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Diasorin, Abbott, Roche Holding AG, BioMérieux, Becton Dickinson, Bruker, Beckman Coulter, Luminex Corporation and McKesson Corporation, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Septicemia Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Septicemia Diagnostic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Septicemia Diagnostic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Septicemia Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Laboratory Testing
1.2.3 PoC Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Septicemia Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Septicemia Diagnostic Market Perspective (2017-2028)
2.2 Septicemia Diagnostic Growth Trends by Region
2.2.1 Septicemia Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Septicemia Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Septicemia Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Septicemia Diagnostic Market Dynamics
2.3.1 Septicemia Diagnostic Industry Trends
2.3.2 Septicemia Diagnostic Market Drivers
2.3.3 Septicemia Diagnostic Market Challenges
2.3.4 Septicemia Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Septicemia Diagnostic Players by Revenue
3.1.1 Global Top Septicemia Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Septicemia Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Septicemia Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Septicemia Diagnostic Revenue
3.4 Global Septicemia Diagnostic Market Concentration Ratio
3.4.1 Global Septicemia Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Septicemia Diagnostic Revenue in 2021
3.5 Septicemia Diagnostic Key Players Head office and Area Served
3.6 Key Players Septicemia Diagnostic Product Solution and Service
3.7 Date of Enter into Septicemia Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Septicemia Diagnostic Breakdown Data by Type
4.1 Global Septicemia Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Septicemia Diagnostic Forecasted Market Size by Type (2023-2028)
5 Septicemia Diagnostic Breakdown Data by Application
5.1 Global Septicemia Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Septicemia Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Septicemia Diagnostic Market Size (2017-2028)
6.2 North America Septicemia Diagnostic Market Size by Type
6.2.1 North America Septicemia Diagnostic Market Size by Type (2017-2022)
6.2.2 North America Septicemia Diagnostic Market Size by Type (2023-2028)
6.2.3 North America Septicemia Diagnostic Market Share by Type (2017-2028)
6.3 North America Septicemia Diagnostic Market Size by Application
6.3.1 North America Septicemia Diagnostic Market Size by Application (2017-2022)
6.3.2 North America Septicemia Diagnostic Market Size by Application (2023-2028)
6.3.3 North America Septicemia Diagnostic Market Share by Application (2017-2028)
6.4 North America Septicemia Diagnostic Market Size by Country
6.4.1 North America Septicemia Diagnostic Market Size by Country (2017-2022)
6.4.2 North America Septicemia Diagnostic Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Septicemia Diagnostic Market Size (2017-2028)
7.2 Europe Septicemia Diagnostic Market Size by Type
7.2.1 Europe Septicemia Diagnostic Market Size by Type (2017-2022)
7.2.2 Europe Septicemia Diagnostic Market Size by Type (2023-2028)
7.2.3 Europe Septicemia Diagnostic Market Share by Type (2017-2028)
7.3 Europe Septicemia Diagnostic Market Size by Application
7.3.1 Europe Septicemia Diagnostic Market Size by Application (2017-2022)
7.3.2 Europe Septicemia Diagnostic Market Size by Application (2023-2028)
7.3.3 Europe Septicemia Diagnostic Market Share by Application (2017-2028)
7.4 Europe Septicemia Diagnostic Market Size by Country
7.4.1 Europe Septicemia Diagnostic Market Size by Country (2017-2022)
7.4.2 Europe Septicemia Diagnostic Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Septicemia Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Septicemia Diagnostic Market Size by Type
8.2.1 Asia-Pacific Septicemia Diagnostic Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Septicemia Diagnostic Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Septicemia Diagnostic Market Share by Type (2017-2028)
8.3 Asia-Pacific Septicemia Diagnostic Market Size by Application
8.3.1 Asia-Pacific Septicemia Diagnostic Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Septicemia Diagnostic Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Septicemia Diagnostic Market Share by Application (2017-2028)
8.4 Asia-Pacific Septicemia Diagnostic Market Size by Region
8.4.1 Asia-Pacific Septicemia Diagnostic Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Septicemia Diagnostic Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Septicemia Diagnostic Market Size (2017-2028)
9.2 Latin America Septicemia Diagnostic Market Size by Type
9.2.1 Latin America Septicemia Diagnostic Market Size by Type (2017-2022)
9.2.2 Latin America Septicemia Diagnostic Market Size by Type (2023-2028)
9.2.3 Latin America Septicemia Diagnostic Market Share by Type (2017-2028)
9.3 Latin America Septicemia Diagnostic Market Size by Application
9.3.1 Latin America Septicemia Diagnostic Market Size by Application (2017-2022)
9.3.2 Latin America Septicemia Diagnostic Market Size by Application (2023-2028)
9.3.3 Latin America Septicemia Diagnostic Market Share by Application (2017-2028)
9.4 Latin America Septicemia Diagnostic Market Size by Country
9.4.1 Latin America Septicemia Diagnostic Market Size by Country (2017-2022)
9.4.2 Latin America Septicemia Diagnostic Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Septicemia Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Septicemia Diagnostic Market Size by Type
10.2.1 Middle East & Africa Septicemia Diagnostic Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Septicemia Diagnostic Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Septicemia Diagnostic Market Share by Type (2017-2028)
10.3 Middle East & Africa Septicemia Diagnostic Market Size by Application
10.3.1 Middle East & Africa Septicemia Diagnostic Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Septicemia Diagnostic Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Septicemia Diagnostic Market Share by Application (2017-2028)
10.4 Middle East & Africa Septicemia Diagnostic Market Size by Country
10.4.1 Middle East & Africa Septicemia Diagnostic Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Septicemia Diagnostic Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Diasorin
11.1.1 Diasorin Company Details
11.1.2 Diasorin Business Overview
11.1.3 Diasorin Septicemia Diagnostic Introduction
11.1.4 Diasorin Revenue in Septicemia Diagnostic Business (2017-2022)
11.1.5 Diasorin Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Septicemia Diagnostic Introduction
11.2.4 Abbott Revenue in Septicemia Diagnostic Business (2017-2022)
11.2.5 Abbott Recent Developments
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Details
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Septicemia Diagnostic Introduction
11.3.4 Roche Holding AG Revenue in Septicemia Diagnostic Business (2017-2022)
11.3.5 Roche Holding AG Recent Developments
11.4 BioMérieux
11.4.1 BioMérieux Company Details
11.4.2 BioMérieux Business Overview
11.4.3 BioMérieux Septicemia Diagnostic Introduction
11.4.4 BioMérieux Revenue in Septicemia Diagnostic Business (2017-2022)
11.4.5 BioMérieux Recent Developments
11.5 Becton Dickinson
11.5.1 Becton Dickinson Company Details
11.5.2 Becton Dickinson Business Overview
11.5.3 Becton Dickinson Septicemia Diagnostic Introduction
11.5.4 Becton Dickinson Revenue in Septicemia Diagnostic Business (2017-2022)
11.5.5 Becton Dickinson Recent Developments
11.6 Bruker
11.6.1 Bruker Company Details
11.6.2 Bruker Business Overview
11.6.3 Bruker Septicemia Diagnostic Introduction
11.6.4 Bruker Revenue in Septicemia Diagnostic Business (2017-2022)
11.6.5 Bruker Recent Developments
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Details
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter Septicemia Diagnostic Introduction
11.7.4 Beckman Coulter Revenue in Septicemia Diagnostic Business (2017-2022)
11.7.5 Beckman Coulter Recent Developments
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Details
11.8.2 Luminex Corporation Business Overview
11.8.3 Luminex Corporation Septicemia Diagnostic Introduction
11.8.4 Luminex Corporation Revenue in Septicemia Diagnostic Business (2017-2022)
11.8.5 Luminex Corporation Recent Developments
11.9 McKesson Corporation
11.9.1 McKesson Corporation Company Details
11.9.2 McKesson Corporation Business Overview
11.9.3 McKesson Corporation Septicemia Diagnostic Introduction
11.9.4 McKesson Corporation Revenue in Septicemia Diagnostic Business (2017-2022)
11.9.5 McKesson Corporation Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer